ResMed (RMD) reported Q1 earnings of $2.20 per share on $1.22 billion sales, beating estimates. Stock rose 4% after-hours to 249, forming a base at 255.18.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
ResMed (RMD) reported Q1 earnings of $2.20 per share on $1.22 billion sales, beating estimates. Stock rose 4% after-hours to 249, forming a base at 255.18.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.